Surgery for Bile Duct Cancer: Two Surgical Approaches
Part of Cancer, Digestive system clinical trials.
This trial compares two different surgical approaches for treating bile duct cancer (cholangiocarcinoma) to see which method works better and is safer. You would undergo surgery and have your recovery and outcomes closely monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Confirmed bile duct cancer (cholangiocarcinoma, gallbladder cancer, or liver bile duct cancer with lymph node spread)
- No prior chemotherapy, immunotherapy, or other cancer treatments for this cancer
- Good liver function and overall health (ECOG score 0-1, able to do normal activities or mostly normal)
- Adequate blood counts and kidney/liver function (based on recent lab work)
- Life expectancy of at least 12 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug combination given before surgery to shrink bile duct cancer tumors, potentially making surgery more successful. It is for patients whose cancer is locally advanced or has spread to only a few places.
This trial uses a test called MiniPDX, which grows a tiny sample of your tumor in mice to see which drugs work best. After your surgery, you'll receive chemotherapy chosen specifically for your cancer to help prevent it from coming back.
This study tests whether combining chemotherapy and radiation therapy after surgery improves outcomes for patients with bile duct or gallbladder cancer. It's designed for patients whose surgery showed signs the cancer might come back.
This trial tests a chemotherapy approach after surgery for bile duct or gallbladder cancers. The goal is to see if giving chemotherapy based on a detailed analysis of your tumor (called 3D-PTA) helps prevent the cancer from coming back.
This trial tests whether receiving chemotherapy (cisplatin, gemcitabine, and nab-paclitaxel) before surgery can improve outcomes for people with high-risk bile duct or gallbladder cancer. It compares this approach to going straight to surgery.
This trial tests a combination of two chemotherapy drugs and an immunotherapy drug given before surgery for bile duct cancer. The goal is to see if this approach shrinks tumors and lowers the chance of cancer coming back after surgery.
Hear when a new BTC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.